虚弱对平衡的影响,跌倒风险和萨尔科佩尼老年人的运动恐惧症
Metehan Yana1,2, Ecem Çoroğlu3, Musa Güneş4
1Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Karabük University, Karabuk, Türkiye. metehanyana@karabuk.edu.tr.
BMC geriatrics
|December 5, 2025
概括
患有皮症的老年人经历了更高的脆弱性,跌倒风险和运动恐惧症,特别是女性. 虚弱与跌倒风险增加,跌倒恐惧和平衡不佳有关,这凸显了康复规划中需要进行全面评估的需要.
科学领域:
- 老年学是一门学科.
- 老年医学 老年医学
- 康复科学 康复科学 康复科学
背景情况:
- 在老年人中,脆弱性和肉症之间的相互作用已经确立,但影响脆弱性的因素需要进一步调查.
- 主要的sarcopenia在老年人群中是一个重大的健康问题,经常与脆弱共存.
研究的目的:
- 为了检查与平衡,跌倒风险和被诊断患有初级萨科佩尼亚的老年人中的动态恐惧症的脆弱程度之间的关系.
- 为了比较这些性别之间的关联在老年人与原发性sarcopenia.
主要方法:
- 一项涉及68名老年人 (32名女性,36名男性) 患有原发性sarcopenia的横截面研究.
- 萨尔科佩尼亚的评估包括握力,骨肌肉质量和身体表现.
- 评估的脆弱性 (埃德蒙顿脆弱性尺度),平衡 (强力板),跌倒风险 (丹恩跌倒风险评估尺度) 和运动恐惧症 (坦帕运动恐惧症尺度).
主要成果:
- 与男性相比, Sarcopenic 雌性表现出明显更高的脆弱性,跌倒风险,运动恐惧症和较差的平衡 (p < 0.05).
- 软骨的老年人中,软骨的发病率为51.5%,女性的平均软骨得分较高 (7.53比5.67).
- 虚弱与跌倒风险 (r=0.603) 和运动恐惧症 (r=0.510) 有正相关性,与平衡稳定性 (r=-0.249至-0.265) 有负相关性.
结论:
- 与男性相比,sarcopenic女性面临更大的脆弱性,跌倒风险,运动恐惧症和失衡.
- 软骨的老年人增加的虚弱与更高的跌倒恐惧,运动恐惧症和平衡缺陷有关.
- 评估脆弱性和相关因素对于有效的康复计划至关重要.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
221
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
221
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
216
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
216
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
183
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183


